Théa and Olix Pharmaceuticals sign a new partnership
Thea2023-04-07T15:35:30+02:00Théa and Olix Pharmaceuticals sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Thea2023-04-07T15:09:56+02:00Théa and Gallimedix, Inc sign a new partnership
Théa and Curacle sign a new partnership
Thea2021-11-04T18:19:18+01:00Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Thea2021-10-25T14:39:05+02:00Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive licensing agreement
Thea2021-10-25T14:35:35+02:00Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive agreement
Thea2021-09-16T16:12:27+02:00Théa and Coave Therapeutics sign an exclusive licensing, co development and commercialization agreement
Théa and Coave Therapeutics announce their partnership
Thea2021-08-02T10:55:58+02:00Théa and Coave Therapeutics announce their partnership
Signing of an exclusive Licensing Agreement with Ripple Therapeutics Corp.
Thea2021-01-18T15:00:02+01:00Théa Open Innovation signs an exclusive Licensing Agreement for the rights on Ripple Therapeutics Corporation lead product, IBE-814 for North America and Europe.
Théa and EVEON announce their partnership
Thea2021-01-22T11:05:04+01:00EVEON, designer and maker of medical devices for the preparation and administration of drugs, and Théa, European leader in the field of ophthalmology, announce their partnership in the development of innovative medical technologies.
Consolidation of the collaboration with OliX
Thea2021-01-14T15:32:16+01:00OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa to Develop siRNA Therapeutics for Ophthalmic Diseases.